As a Biopharmaceutical company listed on the ASX (ASX:CXS) ChemGenex Pharmaceuticals is a leader in the Australian Biotech sector. Oncology is the primary focus with a developing late stage product pipeline.
Download our latest Annual Report
Download our latest Corporate Presentation
Download a Corporate Factsheet
Download Share Registry details
Latest News
July 14th, 2010ChemGenex and U.S. FDA Agree on Potential Regulatory Pathway for OMAPRO™
June 7th, 2010ChemGenex Announces Positive Safety Data on OMAPRO™ Presented at ASCO
May 4th, 2010